Neutral
0.0
AbbVie (NYSE:ABBV) Given New $265.00 Price Target at Cantor Fitzgerald
AbbVie (NYSE:ABBV – Get Free Report) had its target price boosted by analysts at Cantor Fitzgerald from $240.00 to $265.00 in a research report...